FAQs Frequently asked questions about MSM supplements Sign up for our newsletter and get a 10 voucher Sign up for our newsletter, receive your personal 10 voucher and look forward to exciting insights into the latest product innovations, giveaways and health tips so you'll be well accompanied on your journey to well-being.
Published by Eli Lilly in December 2025, the results showed: Average weight loss of 28.7% at the 12mg dose over 68 weeks comparable to TRIUMPH-1 at the same dose Significant reductions in WOMAC pain scores a validated measure of knee pain and function More than 1 in 8 patients on retatrutide were completely free of knee pain by the end of the trial compared with less than 1 in 25 on placebo Significant improvements in physical function, stair climbing, and walking distance This matters clinically because knee osteoarthritis and obesity are deeply intertwined each kilogram of body weight lost reduces knee joint load by approximately 4 kilograms during walking
The company behind the products
Ongoing support throughout your weight loss journey
Disclosures Yoshifumi Saisho received honoraria from Takeda Pharmaceutical Co
While tirzepatide does not directly cause sweating through its pharmacological action, several mechanisms may explain why patients experience increased perspiration during treatment: Hypoglycemia is the most clinically significant cause of sweating in patients taking tirzepatide, particularly when combined with insulin or sulfonylureas